Media Coverage: Scripps MD Anderson Treats Patient with New Cancer Therapy
Note to Patients: The following news is posted for archival purposes only. Scripps no longer has a formal partnership with MD Anderson Cancer Center. We currently provide comprehensive cancer care through Scripps Cancer Center.
Local man is first in San Diego County to receive new drug
Cancer patient William Apodaca and Dr. Marin Xavier, medical oncologist at Scripps MD Anderson Cancer Center and a physician with Scripps Clinic Medical Group
Local man is first in San Diego County to receive new drug
A San Diego man with a rare form of cancer was recently treated at Scripps MD Anderson Cancer Center with a new targeted cancer therapy. William Apodaca of Paradise Hills received a dose of the radioactive drug Lutathera at Scripps Mercy Hospital San Diego, making him the first patient in the region to receive the new FDA-approved medication.
“This medication is pretty much giving me a second chance at life,” Apodaca told 10 News.
View the segment on 10 News: San Diego patient treated with new targeted cancer therapy
Read the story in The San Diego Union-Tribune: Drug effective against cancer that killed Steve Jobs arrives in San Diego
The segment on KUSI, “Cancer Treatment Milestone at Scripps MD Anderson,” is no longer available.
Media Contact
- Steve Carpowich
- 858-312-0328
- carpowich.stephen@scrippshealth.org